AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 19, 2024 | $490,000 | Replaced |
| 1st Quarter - Amendment | Nov 8, 2024 | $375,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; price transparency for clinical laboratory services, FY 2024 budget and appropriations processes, FDA regulation of clinical laboratory services. Saving Access to Laboratory Services Act H.R. 2377/S. 1000; H.R. 3791, Improving Data in Public Health Act; H.R. 3248, Diagnostic Lab Testing Transparency Act; H.R. 5378, Lower Costs, More Transparency Act; S. 3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS New | — |
Medicare/Medicaid MMM
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93). Saving Access to Laboratory Services Act H.R. 2377/S. 1000.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS New | — |
Health Issues HCR
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; price transparency for clinical laboratory services. Saving Access to Laboratory Services Act H.R. 2377/S. 1000; H.R. 4882, Clinical Laboratory Price Transparency Act of 2023; H.R. 5378, Lower Costs, More Transparency Act; S. 3548, Health Care Prices and Information to Consumers Explained Transparency Act; S. 3545, Improving DATA in Public Health Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.